$1.61
-0.01-0.62%
Last update: 11:01 AM
15 minutes delayed
Lyell Immunopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lyell Immunopharma using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma | -$0.04 | -$0.20 | — | — | $27.00K | — | — | — | 08/06/2024 | Get Alert |
LYEL | Lyell Immunopharma | -$0.18 | -$0.21 | -$0.15 | 28.57% | $65.00K | — | $3.00K | — | 05/06/2024 | Get Alert |
LYEL | Lyell Immunopharma | $0.00 | -$0.23 | -$0.17 | 26.09% | $48.39M | — | $13.00K | — | 02/28/2024 | Get Alert |
LYEL | Lyell Immunopharma | -$0.18 | -$0.25 | -$0.17 | 32.00% | $3.00K | — | $25.00K | — | 11/07/2023 | Get Alert |
LYEL | Lyell Immunopharma | -$0.04 | -$0.23 | -$0.04 | 82.61% | $35.74M | — | $27.00K | — | 08/08/2023 | Get Alert |
LYEL | Lyell Immunopharma | -$0.20 | — | -$0.18 | — | $553.00K | — | $65.00K | — | 05/04/2023 | Get Alert |
LYEL | Lyell Immunopharma | -$0.17 | — | $0.00 | — | $2.82M | — | $48.39M | — | 02/28/2023 | Get Alert |
LYEL | Lyell Immunopharma | -$0.15 | — | -$0.18 | — | $2.75M | — | $3.00K | — | 11/08/2022 | Get Alert |
LYEL | Lyell Immunopharma | -$0.89 | — | -$0.04 | — | $2.63M | — | $35.74M | — | 08/04/2022 | Get Alert |
LYEL | Lyell Immunopharma | — | — | -$0.20 | — | $2.44M | — | $553.00K | — | 05/10/2022 | Get Alert |
LYEL | Lyell Immunopharma | — | — | -$0.17 | — | — | — | $2.82M | — | 03/29/2022 | Get Alert |
LYEL | Lyell Immunopharma | -$1.78 | -$0.27 | -$0.15 | 44.44% | $1.07M | $2.30M | $2.75M | 19.78% | 11/12/2021 | Get Alert |
LYEL | Lyell Immunopharma | -$7.54 | — | -$0.89 | — | $3.12M | — | $2.63M | — | 08/12/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-06 | $-0.15 | $-0.21 | 28.6 % |
Dec 2023 | 2024-02-28 | $-0.17 | $-0.23 | 26.1 % |
Sep 2023 | 2023-11-07 | $-0.17 | $-0.25 | 32.0 % |
Jun 2023 | 2023-08-08 | $-0.04 | $-0.23 | 82.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-12 | $2.76M | $2.30M | 19.8 % |
Lyell Immunopharma (LYEL) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 6, 2024 for Q1.
The Actual EPS was $-0.15, which beat the estimate of $-0.21.
The Actual Revenue was $3K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.